about
The effect of GABA receptor ligands in experimental spina bifida occultaIn utero exposure to valproic acid changes sleep in juvenile rats: a model for sleep disturbances in autism.Teratogenic effects of antiepileptic drugsEGR1 controls divergent cellular responses of distinctive nucleus pulposus cell typesMode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin--developmental effects of valproic acid.Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.Fetal surgery for myelomeningocele: patient selection, perioperative management and outcomes.Cell-autonomous and cell-to-cell signalling events in normal and altered neuronal migration.Drug and environmental factors associated with adverse pregnancy outcomes. Part II: Improvement with folic acid.The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities.Postulated mechanisms underlying the development of neural tube defects. Insights from in vitro and in vivo studies.Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells.Homocysteine modifies development of neurulation and dorsal root ganglia in chick embryos.Exposure-disease continuum for 2-chloro-2'-deoxyadenosine (2-CdA), a prototype teratogen: induction of lumbar hernia in the rat and species comparison for the teratogenic responses.Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity.Valproic acid disrupts the biomechanics of late spinal neural tube closure in mouse embryos.Molecular approaches to developmental malformations using analogous forms of valproic acid.Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.Antiepileptic drugs and pregnancy outcomes.
P2860
Q24803370-7029CB36-5B28-4558-9F0C-FCDFCE2165CAQ34125907-F81BDE02-B6DB-420F-96D9-2905996C15FDQ34267151-4288399C-DE99-483E-88C8-021024E8C47DQ35956748-DA0F9769-9972-4545-84D9-D54F713FA826Q36370360-015EB4CF-4C94-4136-81F8-0E5EE86D455FQ37228601-1F7A12E7-6B01-40E0-92F5-0A59E42B9679Q37919284-AB609F02-9FB9-438C-B181-4B3259B15080Q37958903-C92BC4B3-3020-4AD0-9D29-EEAC0B178F3BQ38549821-4076918F-3ED0-4A5A-BCF9-06136AE25A05Q39570462-5003C1F5-A291-4CDA-B126-E0CA6024EE8BQ40908139-64FAEBE8-3B2A-4A20-93BC-CBC823839F64Q40965816-26B508F4-3894-4A37-8EDF-55E8D4FF4BD0Q43956181-B2B4B632-0A99-4DE2-94CE-DB30D26A2491Q44062760-454D13F2-33EA-44CE-BDFE-C41E1B24516BQ46690406-C8BCF257-CC75-42F5-9303-21CD376864B7Q49964025-EFEBFAAD-06B6-48A4-B354-3D4DEDC7395BQ52016604-81D05D3A-9D14-484D-B933-C91788CE99F8Q52194596-140F74D4-46B6-4D22-8086-37A4185F974CQ55716842-BD5446D3-0436-4AA3-B5C8-603E24E64EC9
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Valproic acid-induced spina bifida: a mouse model
@ast
Valproic acid-induced spina bifida: a mouse model
@en
Valproic acid-induced spina bifida: a mouse model
@nl
type
label
Valproic acid-induced spina bifida: a mouse model
@ast
Valproic acid-induced spina bifida: a mouse model
@en
Valproic acid-induced spina bifida: a mouse model
@nl
prefLabel
Valproic acid-induced spina bifida: a mouse model
@ast
Valproic acid-induced spina bifida: a mouse model
@en
Valproic acid-induced spina bifida: a mouse model
@nl
P2093
P356
P1476
Valproic acid-induced spina bifida: a mouse model
@en
P2093
P2860
P304
P356
10.1002/TERA.1420450208
P407
P577
1992-02-01T00:00:00Z